The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in hormone receptor positive patients with ductal carcinoma in situ
Conflict of interest
We declare that I have no conflict of interest.
Ethical approval
Not applicable.
Informed consent
Not applicable.
Research involving human and animal participants
This article does not contain any studies with human participants or animals performed by any of the authors.
Comments (0)